The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Neurothekeoma

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Neurothekeoma

 

High impact information on Neurothekeoma

  • Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma [2].
  • We studied a series of 11 cellular neurothekeomas using paraffin immunoperoxidase staining with microphthalmia transcription factor (Mitf), NKI/C3, and S-100 [2].
  • In contrast, immunoreactivity to S-100 protein is only positive in 3 of 12 cases of cellular neurothekeoma [3].
  • PGP9.5: a marker for cellular neurothekeoma [3].
  • All cellular neurothekeomas failed to express S-100 protein, whereas the three myxomatous types were strongly positive for this marker [4].
 

Chemical compound and disease context of Neurothekeoma

 

Gene context of Neurothekeoma

  • These results, such as the concomitant expressions of PGP9.5/S-100A6 and PG-M1/CD68 (KP-1), support the theory of multiple differentiation in cellular neurothekeomas [6].
  • RESULTS: All 11 neurothekeoma cases were positive for S100A6 protein (four cases, weak/1+; seven cases, strong/2+), corresponding to 100% sensitivity [5].
  • The significance of the expression of CD10 in this cellular neurothekeoma is unclear [6].

References

  1. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi. Shah, I.A., Gani, O.S., Wheler, L. Pathol. Res. Pract. (1997) [Pubmed]
  2. Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Page, R.N., King, R., Mihm, M.C., Googe, P.B. Mod. Pathol. (2004) [Pubmed]
  3. PGP9.5: a marker for cellular neurothekeoma. Wang, A.R., May, D., Bourne, P., Scott, G. Am. J. Surg. Pathol. (1999) [Pubmed]
  4. Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations. Barnhill, R.L., Dickersin, G.R., Nickeleit, V., Bhan, A.K., Muhlbauer, J.E., Phillips, M.E., Mihm, M.C. J. Am. Acad. Dermatol. (1991) [Pubmed]
  5. Antibody to S100a6 protein is a sensitive immunohistochemical marker for neurothekeoma. Fullen, D.R., Lowe, L., Su, L.D. J. Cutan. Pathol. (2003) [Pubmed]
  6. Cellular neurothekeoma with histiocytic differentiation. Misago, N., Satoh, T., Narisawa, Y. J. Cutan. Pathol. (2004) [Pubmed]
 
WikiGenes - Universities